Skip to main content

Advertisement

Log in

The place for surgical treatment for AVM involving the temporal lobe

  • Clinical Article
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Objective

The objective of this study was to analyze preoperative symptoms and late clinical outcomes in patients who underwent surgical treatment of arterio-venous malformations (AVMs) of the temporal lobe, including those involving the Sylvian fissure (SF) and the lateral wall of the inferior ventricular horns—with special respect to postoperative hemiparesis and visual field defects (VFD).

Methods

Between 1990 and 2007, 44 patients (n = 22 women, n = 22 men) with a mean age of 41 (12–67) years were operated on an AVM of the temporal lobe. All data had been collected prospectively. Patients’ charts, as well as surgical reports and outpatient files, were analyzed. Thirteen patients showed an involvement of the SF, and six were localized partially in the lateral wall of the temporal horn. Eight AVMs were located in the temporo-mesial region. Fourteen patients had an AVM located mainly within the visual pathway. In 24 cases, the AVM was located in the dominant hemisphere. The AVMs were classified by the Spetzler–Martin grading system (SM). Visual fields were assessed in all patients pre- and postoperatively by independent ophthalmological examiners.

Results

The initial symptoms leading to the diagnosis of the AVM were seizures in 20 cases (45%), headache without hemorrhage in six cases (14%), incidental finding in five cases (11%), and tinnitus in two cases (5%). Hemorrhage had occurred in 15 cases (34%). Based on SM, 7 AVMs were grade I, 17 grade II, 17 grade III, and 3 grade IV. Preoperatively, seven patients presented with a VFD and two with a hemiparesis. Postoperatively, 8 of 44 (18%) patients presented with a new hemiparesis, remaining permanent in 3 of 44 (7%). In two of these patients, the AVMs were localized temporo-mesially (n = 2/8, 25%). Seven patients (19%) showed a new significant postoperative VFD, and in addition, three patients had worsening of their preexisting VFD (3/7, 43%). Postoperative angiography verified complete AVM occlusion in 43 of 44 (98%) cases. One patient needed reoperation for residual AVM; hence, in all patients, complete occlusion before discharge was achieved.

Conclusion

Treatment of temporal lobe AVMs is demanding due to their close spatio-anatomical relationship with important neurovascular structures and the optic radiation. In this surgically treated series, morbidity for a new permanent hemiparesis was 7% and preservation of the visual field could be achieved in almost 90% of all cases. This is a calculable risk for most patients that renders microsurgical resection a justifiable option, even in light of other treatment modalities. The risk for new permanent motor deficits is elevated in temporo-mesial AVMs, and these patients have to be advised accordingly for surgical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brown RD Jr, Wiebers DO, Forbes G, O’Fallon WM, Piepgras DG, Marsh WR, Maciunas RJ (1988) The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 68:352–357

    Article  PubMed  Google Scholar 

  2. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175–1181

    Article  PubMed  Google Scholar 

  3. Deruty R, Pelissou-Guyotat I, Mottolese C, Bascoulergue Y, Amat D (1993) The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature. Acta Neurochir (Wien) 123:101–112

    Article  CAS  Google Scholar 

  4. Drake CG (1979) Cerebral arteriovenous malformations: considerations for and experience with surgical treatment in 166 cases. Clin Neurosurg 26:145–208

    CAS  PubMed  Google Scholar 

  5. Friedman WA (1995) Radiosurgery for arteriovenous malformations. Clin Neurosurg 42:328–347

    CAS  PubMed  Google Scholar 

  6. Hadjipanayis CG, Levy EI, Niranjan A, Firlik AD, Kondziolka D, Flickinger JC, Lunsford LD (2001) Stereotactic radiosurgery for motor cortex region arteriovenous malformations. Neurosurgery 48:70–76, discussion 76–77

    Article  CAS  PubMed  Google Scholar 

  7. Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J, Duong DH, Young WL (1998) Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 29:931–934

    CAS  PubMed  Google Scholar 

  8. Heros RC (1982) Arteriovenous malformations of the medial temporal lobe. Surgical approach and neuroradiological characterization. J Neurosurg 56:44–52

    Article  CAS  PubMed  Google Scholar 

  9. Izawa M, Hayashi M, Chernov M, Nakaya K, Ochiai T, Murata N, Takasu Y, Kubo O, Hori T, Takakura K (2005) Long-term complications after gamma knife surgery for arteriovenous malformations. J Neurosurg 102(Suppl):34–37

    Article  PubMed  Google Scholar 

  10. Jayaraman M, Cloft HJ (2009) Embolization of brain arteriovenous malformations for cure: because we could or because we should? AJNR Am J Neuroradiol 30:107–108

    Article  CAS  PubMed  Google Scholar 

  11. Karnofsky D, Burchenal J (eds) (1949) The clinical evaluation of chemotherapeutic agents in cancer. Columbia University Press, New York

  12. Kihlstrom L, Guo WY, Karlsson B, Lindquist C, Lindqvist M (1997) Magnetic resonance imaging of obliterated arteriovenous malformations up to 23 years after radiosurgery. J Neurosurg 86:589–593

    Article  CAS  PubMed  Google Scholar 

  13. Kjellberg RN (1989) Radiosurgery. Neurosurgery 25:670–672

    Article  CAS  PubMed  Google Scholar 

  14. Kurita H, Kawamoto S, Sasaki T, Shin M, Tago M, Terahara A, Ueki K, Kirino T (2000) Results of radiosurgery for brain stem arteriovenous malformations. J Neurol Neurosurg Psychiatry 68:563–570

    Article  CAS  PubMed  Google Scholar 

  15. Malik GM, Seyfried DM, Morgan JK (1996) Temporal lobe arteriovenous malformations: surgical management and outcome. Surg Neurol 46:106–114, discussion 114–105

    Article  CAS  PubMed  Google Scholar 

  16. Massager N, Regis J, Kondziolka D, Njee T, Levivier M (2000) Gamma knife radiosurgery for brainstem arteriovenous malformations: preliminary results. J Neurosurg 93(Suppl 3):102–103

    PubMed  Google Scholar 

  17. Mounayer C, Hammami N, Piotin M, Spelle L, Benndorf G, Kessler I, Moret J (2007) Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28:518–523

    CAS  PubMed  Google Scholar 

  18. Oka N, Kamiyama K, Nakada J, Endo S, Takaku A (1990) Surgical approach to arteriovenous malformation of the medial temporal lobe—report of three cases. Neurol Med Chir (Tokyo) 30:940–944

    Article  CAS  Google Scholar 

  19. Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I (2009) Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30:99–106

    Article  CAS  PubMed  Google Scholar 

  20. Phi JH, Chung CK (2009) Brain tumors in the mesial temporal lobe: long-term oncological outcome. Neurosurg Focus 27:E5

    Article  PubMed  Google Scholar 

  21. Pollock BE, Lunsford LD, Kondziolka D, Bissonette DJ, Flickinger JC (1996) Stereotactic radiosurgery for postgeniculate visual pathway arteriovenous malformations. J Neurosurg 84:437–441

    Article  CAS  PubMed  Google Scholar 

  22. Schaller C, Jung A, Clusmann H, Schramm J, Meyer B (2004) Rate of vasospasm following the transsylvian versus transcortical approach for selective amygdalohippocampectomy. Neurol Res 26:666–670

    Article  PubMed  Google Scholar 

  23. Schaller C, Schramm J (1997) Microsurgical results for small arteriovenous malformations accessible for radiosurgical or embolization treatment. Neurosurgery 40:664–672, discussion 672–664

    Article  CAS  PubMed  Google Scholar 

  24. Schramm J, Aliashkevich AF (2007) Surgery for temporal mediobasal tumors: experience based on a series of 235 patients. Neurosurgery 60:285–294, discussion 294–285

    Article  PubMed  Google Scholar 

  25. Schramm J, Aliashkevich AF (2008) Surgery for temporal mediobasal tumors: experience based on a series of 235 patients. Neurosurgery 62(6 Suppl 3):1272–1282

    PubMed  Google Scholar 

  26. Song JK, Eskridge JM, Chung EC, Blake LC, Elliott JP, Finch L, Niakan C, Maravilla KR, Winn HR (2000) Preoperative embolization of cerebral arteriovenous malformations with silk sutures: analysis and clinical correlation of complications revealed on computerized tomography scanning. J Neurosurg 92:955–960

    Article  CAS  PubMed  Google Scholar 

  27. Spetzler RF, Zabramski JM (1990) Grading and staged resection of cerebral arteriovenous malformations. Clin Neurosurg 36:318–337

    CAS  PubMed  Google Scholar 

  28. Uribe JS, Vale FL (2009) Limited access inferior temporal gyrus approach to mesial basal temporal lobe tumors. J Neurosurg 110:137–146

    Article  PubMed  Google Scholar 

  29. Valavanis A, Yasargil MG (1998) The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 24:131–214

    CAS  PubMed  Google Scholar 

  30. Vinuela F, Duckwiler G, Guglielmi G (1997) Contribution of interventional neuroradiology in the therapeutic management of brain arteriovenous malformations. J Stroke Cerebrovasc Dis 6:268–271

    Article  CAS  PubMed  Google Scholar 

  31. Yamada S, Brauer F, Dayes L (1998) Surgical techniques for arteriovenous malformations in functional areas: focus on the superior temporal gyrus. Neurol Med Chir (Tokyo) 38(Suppl):222–226

    Article  Google Scholar 

  32. Yamamoto M, Hara M, Ide M, Ono Y, Jimbo M, Saito I (1998) Radiation-related adverse effects observed on neuro-imaging several years after radiosurgery for cerebral arteriovenous malformations. Surg Neurol 49:385–397, discussion 397–388

    Article  CAS  PubMed  Google Scholar 

  33. Yamamoto M, Ide M, Jimbo M, Hamazaki M, Ban S (1998) Late cyst convolution after gamma knife radiosurgery for cerebral arteriovenous malformations. Stereotact Funct Neurosurg 70(Suppl 1):166–178

    Article  PubMed  Google Scholar 

  34. Yeh HS, Kashiwagi S, Tew JM Jr, Berger TS (1990) Surgical management of epilepsy associated with cerebral arteriovenous malformations. J Neurosurg 72:216–223

    Article  CAS  PubMed  Google Scholar 

  35. Yu SC, Chan MS, Lam JM, Tam PH, Poon WS (2004) Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure. AJNR Am J Neuroradiol 25:1139–1143

    PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Azize Boström.

Additional information

Comment

Arteriovenous malformations are challenging lesions to treat, even for experienced vascular neurosurgeons. Temporal AVMs have the additional difficulty of being often in the close vicinity of the optic radiation and vascular supply to eloquent areas. Those in the dominant hemisphere may be associated with Wernicke’s area. This paper describes a single-center experience of 44 patients with temporal AVMs who underwent a microneurosurgical excision. The results of this series reflect the challenges of the treatment: 7% of the patients suffered from a new permanent hemiparesis and 19% of a new visual field deficit. On the other hand, a complete angiographically verified removal of the lesion was achieved in every case. Since endovascular treatment or radiosurgery of AVMs in eloquent areas carry significant risks as well, while the probability of complete obliteration with these modalities is by far <100%, microneurosurgical treatment by an experienced cerebrovascular surgeon remains a very viable option. Surgery has the added benefit of obliterating the lesion immediately. Incomplete embolization may even increase the risk of AVM rupture, and the complete occlusion of AVM after radiosurgery (when achieved) may take 2–3 years, leaving the patient at risk of rupture for quite a long time.

Contrary to the experience of the authors, however, we have found preoperative Onyx embolization often helpful, especially in larger AVMs. When multimodal treatment is chosen, we plan the surgery as soon as possible after the embolization (even on the same day) to minimize the time the AVM remains only partially occluded to prevent hemorrhagic complications. But we do agree with the authors that multimodal treatment should only be chosen when it provides true benefits that outweigh the combined risks of multiple treatment sessions.

Aki Laakso

Mika Niemelä

Juha Hernesniemi

Helsinki, Finland

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boström, A., Schaller, K., Seifert, J. et al. The place for surgical treatment for AVM involving the temporal lobe. Acta Neurochir 153, 271–278 (2011). https://doi.org/10.1007/s00701-010-0885-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-010-0885-1

Keywords

Navigation